We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Latest Generation Acoustic Biosensors Launched in Europe

By LabMedica International staff writers
Posted on 05 Oct 2011
Print article
The latest addition to a line of acoustic biosensors is now available for purchase by European biotech researchers and other life scientists.

Acoustic biosensors do not require complex labeling methods; they are real-time analytical systems rather than equilibrium and can be used to investigate living cells rather than fixed cells or purified proteins. A leader in the field of acoustic biosensors, SAW Instruments GmbH (Bonn, Germany), recently unveiled the samX, the latest high-end addition to the sam range of acoustic biosensors. The samX features eight analysis channels and adaptable routing that expands the workflow options available for increased power and flexibility.

The new system uses SAW’s proven proprietary surface acoustic wave technology to detect mass binding and protein conformational changes on whole cells. Surface acoustic wave technology is based on the ability of a wave of energy to travel across the surface of a material. Each surface has a typical inherent elasticity affecting the way the energy of the wave dissipates as it travels across the surface of the material being analyzed. The technology developed and employed by SAW instruments is capable of accurately interpreting this information in order to provide real time readouts measuring binding and conformational changes in the samples through which the wave passes.

The new samX has two sensor chips for higher-end users, rather than the single chip of existing sam5 models, increasing the number of channels to eight, further facilitating the parallel processing of samples. In addition, different ligands can now be immobilized on-line at each chip position automatically, without the need for time-consuming, off-line protein loading.

Dr Markus Perpeet, managing director of SAW, said, “We are very excited to introduce users to the samX, which further extends the flexibility offered by our range of biosensors. The new system facilitates more complex assay design and can be easily adapted to meet the needs of each user, while increasing throughput speed and accuracy. It is particularly well suited to providing binding constants and kinetics data for ligands binding to membrane targets on cells, while results are obtained significantly faster than those from equilibrium-based methods.”

Related Links:
SAW Instruments GmbH


New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Automated Blood Typing System
IH-500 NEXT
New
Flu Test
ID NOW Influenza A & B 2
New
Sulfidoleukotrienes (sLT) Assay
CAST ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.